SCHEMBL21299883

SCHEMBL21299883

CCN(C)c1nc(NC2COC2)cc(C(C)(C)CCCCN(C)c2nc(NC3COC3)cc(C(C)(C)C)n2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17300776 0.88 EHMT2 (0.32) —
SCHEMBL17300773 0.84 EHMT2 (0.34) —
SCHEMBL17300827 0.82 EHMT2 (0.34) —
SCHEMBL17300800 0.81 EHMT2 (0.35) —
SCHEMBL17300774 0.79 EHMT2 (0.38) —
SCHEMBL17300802 0.77 HRH4 (0.42) —
SCHEMBL19957516 0.73 HCRTR1 (0.33) —
SCHEMBL15830339 0.73 KCNN2 (0.35) —
SCHEMBL17300824 0.71 HRH3 (0.35) —
SCHEMBL17300795 0.70 HRH3 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935247-B1 PRMT5 INHIBITORS AND USES THEREOF EPIZYME INC (US) 2019-08-28 — — EP disclosed
Send feedback